Magazine article Information Today

Microsoft Acquisition Moves into World of Life Sciences

Magazine article Information Today

Microsoft Acquisition Moves into World of Life Sciences

Article excerpt

[FEATURED PRODUCT]

Microsoft keeps getting bigger. In a move to help strengthen its position in life sciences and see its vision of a "dynamic, patient-centric health system" materialize, Microsoft recently signed an agreement with Merck & Co., Inc. to acquire certain assets of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics, LLC. Rosetta Biosoftware offers solutions in biological research, drug discovery and development, and translational medicine.

According to the agreement, Merck will become a customer of Microsoft's Amalga Life Sciences platform, which was introduced in April and was designed to assist researchers in organizing scientific data collected from their work. Current programs being used just weren't designed to handle the complex genome research being done today. Amalga Life Sciences lets scientists and researchers redesign, manage, and control the process of their research to increase productivity, reduce errors, and improve decision making.

[ILLUSTRATION OMITTED]

Merck looks forward to "collaborating with Microsoft to develop new bioinformatic solutions to enable and expedite drug discovery and development," according to a statement from Rupert Vessey, vice president of Merck Research Laboratories. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.